These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294 [TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation. Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469 [TBL] [Abstract][Full Text] [Related]
7. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure]. Jerie P; Kremer HJ; Uhlír O; Widimský J Vnitr Lek; 1997 Jun; 43(6):351-8. PubMed ID: 9601863 [TBL] [Abstract][Full Text] [Related]
8. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic]. Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474 [TBL] [Abstract][Full Text] [Related]
9. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
11. The effects of lisinopril on serum catecholamine concentrations both at rest and on exercise in patients with congestive cardiac failure. A double blind, placebo controlled, parallel group study. Fahy G; Deb B; Robinson K; Graham I Ir Med J; 1993; 86(4):134-5. PubMed ID: 8395488 [TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
13. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K; J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224 [TBL] [Abstract][Full Text] [Related]
14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
15. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. Verho M; Bückert C; Freude J; Jaeger S; Pahnke K Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674 [TBL] [Abstract][Full Text] [Related]
16. [The role of ACE-inhibition in the therapy of chronic heart insufficiency]. Drexler H; Just H Wien Med Wochenschr; 1990 Jan; 140(1-2):40-5. PubMed ID: 2137955 [TBL] [Abstract][Full Text] [Related]
17. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? Ahmed A J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029 [TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin converting enzyme inhibition on renal function in the treatment of heart failure. Levine TB Clin Ther; 1989; 11(4):495-502. PubMed ID: 2673517 [TBL] [Abstract][Full Text] [Related]
19. [Renal function during treatment of chronic renal failure with angiotensin converting enzyme inhibitors]. Heitmann M; Rasmussen K; Nielsen JI; Møgelvang JC Ugeskr Laeger; 1995 Sep; 157(39):5381-4. PubMed ID: 7483050 [TBL] [Abstract][Full Text] [Related]
20. [Effect of converting enzyme inhibitors in cardiac insufficiency mortality in the elderly]. Kirancumar ; dos Reis RP; Correia JF Rev Port Cardiol; 1992 Jun; 11(6):553-8. PubMed ID: 1503788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]